Recombinant vaccine against hepatitis E: Duration of protective immunity in rhesus macaques

Vaccine

Volumn 20, Issue 27-28, 2002, Pages 3285-3291

  Zhang, Mingdong ^a   Emerson, Suzanne U ^a   Nguyen, Hanh ^a   Engle, Ron ^a   Govindarajan, Sugantha ^b   Blackwelder, William C ^c   Gerin, John ^d   Purcell, Robert H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^c BIOLOGICS CONSULTING GROUP INC   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

56kDa capsid protein; Duration of protection; Hepatitis E; Macaques; Recombinant vaccine

Indexed keywords

CAPSID PROTEIN; RECOMBINANT VACCINE; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXPERIMENTAL INFECTION; HEPATITIS E; HEPATITIS E VIRUS; IMMUNITY; IMMUNOGENICITY; INSECT CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CAPSID PROTEINS; DNA, VIRAL; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MACACA MULATTA; TIME FACTORS; VACCINES, SYNTHETIC; VIRAL HEPATITIS VACCINES;

EID: 0037055962     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00314-6     Document Type: Article

References (16)

1. Purcell RH, Emerson SU. Hepatitis E virus. In: Fields BN, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields Virology, 4th ed. Philadelphia: Lippincott-Raven Publishers, 2001. p. 3051-61.
2. Chauhan A., Jameel S., Dilawari J.B., Chawla Y.K., Kaur U., Ganguly N.K. Hepatitis E virus transmission to a volunteer. Lancet. 341:1993;149-150.
3. Tsarev S.A., Emerson S.U., Reyes G.R., Tsareva T.S., Legters L.J., Malik I.A.et al. Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci USA. 89:1992;559-563.
4. Pattanyak S. In Magnitude of the Problem of Hepatitis and Directions for Research, Prevention and Control. New Delhi (India): WHO, 1986. p. 1-13.
5. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 70:1981;252-255.
6. Aggarwal R., Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol. 15:2000;9-20.
7. Tam A., Smith M., Guerra M., Huang C., Bradley D., Fry K.et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 185:1991;120-131.
8. Zafrullah M., Ozdener M.H., Panda S.K., Jameel S. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol. 71:1997;9045-9053.
9. Tsarev S.A., Tsareva T.S., Emerson S.U., Govindarajan S., Shapiro M., Gerin J.L.et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA. 91:1994;10198-10202.
10. Robinson R.A., Burgess W.H., Emerson S.U., Leibowitz R.S., Sosnovtseva S.A., Tsarev S.et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expression Purif. 12:1998;75-84.
11. Tsarev S.A., Tsareva T.S., Emerson S.U., Govindarajan S., Shapiro M., Gerin J.L.et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine. 15:1997;1834-1838.
12. Tsarev S.A., Tsareva T.S., Emerson S.U., Kapikian A.Z., Ticehurst J., London W.et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis. 168:1993;369-378.
13. Hollander M, Wolfe D. Nonparametric Statistical Methods. New York: Wiley, 1973.
14. Schofield D.J., Glamann J., Emerson S.U., Purcell R.H. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol. 74:2000;5548-5555.
15. Van Damme P., Leroux-Roels G., Law B., Diaz-Mitoma F., Desombere I., Collard F.et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol. 65:2001;6-13.
16. Arankalle V.A., Chadha M.S., Chobe L.P. Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatol. 30:1999;199-204.